253 related articles for article (PubMed ID: 902377)
21. Influence of sodium nitroprusside and dobutamine on the haemodynamic effects produced by each other.
Meretoja OA
Acta Anaesthesiol Scand; 1980 Jun; 24(3):195-8. PubMed ID: 7445937
[TBL] [Abstract][Full Text] [Related]
22. Combined haemodynamic effects of low doses of dopamine and dobutamine in patients with acute infarction and cardiac failure.
el Allaf D; Cremers S; D'Orio V; Carlier J
Arch Int Physiol Biochim; 1984 Nov; 92(4):S49-55. PubMed ID: 6085239
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J
Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868
[TBL] [Abstract][Full Text] [Related]
24. Degree of external force to the left ventricle determines hemodynamic response to nitroprusside in failing hearts: comparison with the response to dobutamine.
Yamamoto K; Masuyama T; Nagano R; Doi Y; Naito J; Mano T; Kondo H; Hori M; Kamada T
J Cardiovasc Pharmacol; 1995 Oct; 26(4):596-602. PubMed ID: 8569221
[TBL] [Abstract][Full Text] [Related]
25. Combined therapy with digoxin and nitroprusside in heart failure complicating acute myocardial infarction.
Raabe DS
Am J Cardiol; 1979 May; 43(5):990-4. PubMed ID: 433783
[No Abstract] [Full Text] [Related]
26. [The effect of sodium nitroprusside and dobutamine on the ventricular myocardium in patients with severe left cardiac insufficiency].
Cyran J; Bolte HD
Verh Dtsch Ges Inn Med; 1978; (84):683-6. PubMed ID: 742099
[No Abstract] [Full Text] [Related]
27. Effects of nitroprusside and dopamine on pulmonary arterial vasculature in children after cardiac surgery.
Stephenson LW; Edmunds LH; Raphaely R; Morrison DF; Hoffman WS; Rubis LJ
Circulation; 1979 Aug; 60(2 Pt 2):104-10. PubMed ID: 445765
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic effects of nitroprusside in infants with a large ventricular septal defect.
Beekman RH; Rocchini AP; Rosenthal A
Circulation; 1981 Sep; 64(3):553-8. PubMed ID: 7261287
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
Franciosa JA; Pierpont G; Cohn JN
Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
[TBL] [Abstract][Full Text] [Related]
30. Comparison of dopamine and dobutamine therapy during intraaortic balloon pumping for the treatment of postcardiotomy low-output syndrome.
Sterling RP; Taegtmeyer H; Turner SA; Walker WE; Cooley DA
Ann Thorac Surg; 1984 Jul; 38(1):37-41. PubMed ID: 6610395
[TBL] [Abstract][Full Text] [Related]
31. Effects of the automated management of hypertension after open heart surgery. The relevance of the initial systemic vascular resistance as index for predicting hemodynamic response to computer-controlled nitroprusside infusion.
Pomer S; Elert O; Satter P
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):207-13. PubMed ID: 6715091
[TBL] [Abstract][Full Text] [Related]
32. Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.
Capomolla S; Febo O; Opasich C; Guazzotti G; Caporotondi A; La Rovere MT; Gnemmi M; Mortara A; Vona M; Pinna GD; Maestri R; Cobelli F
Eur J Heart Fail; 2001 Oct; 3(5):601-10. PubMed ID: 11595609
[TBL] [Abstract][Full Text] [Related]
33. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
[TBL] [Abstract][Full Text] [Related]
34. Saterinone, dobutamine, and sodium nitroprusside: comparison of cardiovascular profiles in patients with congestive heart failure.
Kieback AG; Iven H; Stolzenburg K; Baumann G
J Cardiovasc Pharmacol; 1998 Oct; 32(4):629-36. PubMed ID: 9781932
[TBL] [Abstract][Full Text] [Related]
35. [Dopamine and dobutamine in the treatment of severe cardiac failure (author's transl)].
Wirtzfeld A; Klein G; Delius W; Himmler C; Volger E; Davidson J
Dtsch Med Wochenschr; 1978 Dec; 103(48):1915-21. PubMed ID: 710319
[TBL] [Abstract][Full Text] [Related]
36. Comparative vasoactive therapy for heart failure.
Benotti JR; McCue JE; Alpert JS
Am J Cardiol; 1985 Jul; 56(3):19B-24B. PubMed ID: 4025154
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic effects of nitroprusside and furosemide in left ventricular failure.
Franciosa JA; Silverstein SR
Clin Pharmacol Ther; 1982 Jul; 32(1):62-9. PubMed ID: 7083731
[TBL] [Abstract][Full Text] [Related]
38. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.
Monrad ES; Baim DS; Smith HS; Lanoue AS
Circulation; 1986 Mar; 73(3 Pt 2):III168-74. PubMed ID: 3510773
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Baumann G; Ningel K; Permanetter B
J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
[TBL] [Abstract][Full Text] [Related]
40. Sodium nitroprusside therapy in congestive cardiomyopathy-variability in hemodynamic response.
Mookherjee S; Henion W; Warner R; Eich RH; Smulyan H; Obeid AI
J Clin Pharmacol; 1978 Jan; 18(1):67-75. PubMed ID: 338648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
